Ascites
Ascites
Explore linked clinical trials. Standard reference: MESH:M000179139 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS) | Ascites, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, liver disorder, portal hypertension | Recruiting | Not stated | 2026-10-05 | NCT07390344 | |
| Retlirafusp Alfa Plus SOX and Intraperitoneal Nab-Paclitaxel for Advanced Gastric/GEJ Cancer With Malignant Ascites | Ascites, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Active, not recruiting | Not applicable | 2026-10-02 | NCT07855757 | |
| Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites | Ascites, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Not stated | 2026-10-02 | NCT07855640 | |
| Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer | Adnexal Diseases, Ascites, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Not stated | 2026-09-18 | NCT03943316 | |
| The BD Liverty™ TIPS Stent Graft Study | Ascites, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, liver disorder, portal hypertension | Active, not recruiting | Not applicable | 2026-08-27 | NCT05711316 | |
| Proximal Splenic Artery Embolization (PSAE) for the Treatment of Refractory Ascites in Decompensated Cirrhosis | Ascites, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder, portal hypertension | Not yet recruiting | Not applicable | 2026-08-10 | NCT07755059 | |
| Gut Leakage' in Dengue | Ascites, Digestive System Diseases, Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, arbovirus infection, dengue disease, dengue shock syndrome, digestive system disorder, intestinal disorder, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-08-06 | NCT07602920 | |
| Role of Nutritional Intervention for the Treatment of Sarcopenia in Cirrhotic Patients With Refractory Ascites Candidate to Transjugular Intrahepatic Portosystemic Shunt Placement and Identification of Prognostic Factors Related to Clinical Outcome | Ascites, Atrophy, Digestive System Diseases, Fibrosis, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, cirrhosis of liver, liver disorder, muscular atrophy, nervous system disorder | Recruiting | Phase 3 | 2026-07-14 | NCT06814626 | |
| High Dose Albumin in Refractory Ascites | Ascites, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Phase 2 | 2026-06-30 | NCT05867602 | |
| Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource Settings | Ascites, Atrophy, Digestive System Diseases, Digestive System Neoplasms, Fibrosis, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Pleural Effusion, Sarcopenia, Signs and Symptoms, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, muscular atrophy, neoplasm, nervous system disorder, pleural disorder, respiratory system disorder | Not yet recruiting | Not stated | 2026-06-25 | NCT07667608 | |
| QOL and Sarcopenia in Patients With Ascites | Ascites, Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder | Recruiting | Not stated | 2026-06-15 | NCT05726747 | |
| Personalized Nutritional Intervention in Patients Undergoing TIPS Insertion for Refractory Ascites to Prevent Overt Hepatic Encephalopathy | Ascites, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver | Not yet recruiting | Not applicable | 2026-06-08 | NCT07634237 | |
| DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis | Ascites, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, cirrhosis of liver, cirrhotic cardiomyopathy, diastolic heart failure, heart disorder, heart failure | Recruiting | Phase 4 | 2026-05-14 | NCT07322237 | |
| Early TIPS in Patients With Liver Cirrhosis and Ascites | Ascites, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder, portal hypertension | Recruiting | Not applicable | 2026-05-01 | NCT06576934 | |
| SGLT-2 Inhibitors in the Treatment of Ascites | Ascites, Digestive System Diseases, Fibrosis, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, diabetes mellitus, endocrine system disorder, glucose metabolism disease, liver disorder, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Not stated | 2026-05-01 | NCT05999773 | |
| Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis | Ascites, Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, digestive system disorder, esophageal disorder, esophageal varices, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension, portal vein thrombosis | Recruiting | Phase 4 | 2026-04-09 | NCT07521332 | |
| Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites | Ascites, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 1 / Phase 2 | 2026-03-17 | NCT07435701 | |
| Fiber-Optic Navigation During TIPS Creation: A Prospective Pilot Study | Ascites, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder, portal hypertension | Not yet recruiting | Not applicable | 2026-03-13 | NCT07470515 | |
| Transitional Care Program for Fluid Overload in Cirrhosis | Ascites, Digestive System Diseases, Edema, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Not applicable | 2026-03-09 | NCT06174272 | |
| Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis | Ascites, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver | Recruiting | Phase 2 | 2026-02-25 | NCT06764966 | |
| Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites | Ascites, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Recruiting | Phase 3 | 2026-02-03 | NCT05056220 | |
| Pediatric Intravenous Contrast-Enhanced Ultrasound(CEUS) in China | Abdominal Injuries, Abdominal Neoplasms, Ascites, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, injury, neoplasm | Recruiting | Not stated | 2025-12-08 | NCT07113808 | |
| Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites | Ascites, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Phase 1 / Phase 2 | 2025-11-19 | NCT06759064 | |
| Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic Patients | Ascites, Pathologic Processes, Pathological Conditions, Signs and Symptoms | Enrolling by invitation | Phase 3 | 2025-09-29 | NCT06121479 | |
| VICIS - Vienna Cirrhosis Study | Ascites, Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension | Recruiting | Not stated | 2025-09-25 | NCT03267615 |